Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy
Open Access
- 8 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 1010724
Abstract
Immunotherapy has demonstrated great clinical success in the field of oncology in comparison with conventional cancer therapy. However, cancer immunotherapy still encounters major challenges that limit its efficacy against different types of cancers and the patients show minimal immune response to the immunotherapy. To overcome these limitations, combinatorial approaches with other therapeutics have been applied in the clinic. Simultaneously, nano-drug delivery system has played an important role in increasing the antitumor efficacy of various treatments and has been increasingly utilized for synergistic immunotherapy to further enhance the immunogenicity of the tumors. Specifically, they can promote the infiltration of immune cells within the tumors and create an environment that is more sensitive to immunotherapy, particularly in solid tumors, by accelerating tumor accumulation and permeability. Herein, this progress report provides a brief overview of the development of nano-drug delivery systems, classification of combinatory cancer immunotherapy and recent progress in tumor immune synergistic therapy in the application of nano-drug delivery systems.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province
This publication has 121 references indexed in Scilit:
- Covalent Coupling of Nanoparticles with Low-Density Functional Ligands to Surfaces via Click ChemistryInternational Journal of Molecular Sciences, 2013
- Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter studyHead & Neck, 2010
- Understanding and Overcoming Major Barriers in Cancer NanomedicineNanomedicine, 2010
- The Role of Blood Vessels, Endothelial Cells, and Vascular Pericytes in Insulin Secretion and Peripheral Insulin ActionEndocrine Reviews, 2010
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Minireview: Nanoparticles and the Immune SystemEndocrinology, 2010
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotypeNature Reviews Cancer, 2009
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008